Specialty Pharmas initiation details ...

Specialty Pharmas initiation details at Credit Suisse

There are 1 comment on the The Visual Trader story from Jun 29, 2006, titled Specialty Pharmas initiation details at Credit Suisse. In it, The Visual Trader reports that:

Credit Suisse initiates the Specialty Pharmas with an Overweight, as they believe that, on a mkt-cap-weighted basis, their coverage universe will outperform the S&P 500 over the next 6-12 months.

Join the discussion below, or Read more at The Visual Trader.

Pharmacist Canada Dave

Regina, Canada

#1 Jul 6, 2006
Absolutely silly underweight on Mylan because of generic competition.

First I see absolutely no competition with allergan(They don"t even market the same products or even close to the same products.

Barr rated overweight but has exactly the same competitors as Mylan.???

Obviously Credit Suisse has another agenda??

No explanation for underweight on Mylan that has any logical explanation.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Bausch and Lomb Discussions

Title Updated Last By Comments
News Schumer Urges Valeant to Move Jobs to Rochester (Jun '14) Jun '14 Denis Guerin 1
News Can We Solve Our Global Health Challenges? Indu... (Jul '13) Jul '13 Kate 1
martauro (Feb '13) Feb '13 javier 1
Wow Great Deal for Bausch and Lomb employees! (Jun '09) Jul '12 Ex employee 6
News Bausch and Lomb tells its union it remains comm... (Mar '09) Mar '12 bill 2
william fulton soare print- Bausch and Lomb (Mar '09) Feb '12 Charms 3
News B&L plans to cut 300 jobs (Mar '09) Jan '12 happy 16
More from around the web